Body composition affects the response to erythropoiesis-stimulating agents in patients with chronic kidney disease in dialysis

Renal Failure

Volumn 36, Issue 7, 2014, Pages 1073-1077

  Vega, Almudena ^a   Ruiz, Caridad ^a   Abad, Soraya ^a   Quiroga, Borja ^a   Velázquez, Kyra ^b   Yuste, Claudia ^a   Aragoncillo, Inés ^a   López Gómez, Juan Manuel ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b St Columcille s Hospital   (Ireland)

Author keywords

Anemia; Bioimpedance spectroscopy; Fat tissue

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN; PREALBUMIN;

ADIPOSE TISSUE; ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; ARTIFICIAL KIDNEY; BODY COMPOSITION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; ANEMIA; CHRONIC KIDNEY FAILURE; COMPLICATION; MIDDLE AGED;

AGED; ANEMIA; BODY COMPOSITION; CROSS-SECTIONAL STUDIES; ERYTHROPOIETIN; FEMALE; HEMATINICS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED;

EID: 84904603401     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2014.917937     Document Type: Article

References (25)

1. López-Gómez JM, Portolés JM, Aljama P. Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl. 2008;111:S75-S81.
2. Agarwal R, Davis JL, Smith L. Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:98-104.
3. Horl WH, Jacobs C, Macdougall IC. European best practice guidelines 14-16: inadequate response to epoetin. Nephrol Dial Transplant. 2000;15:43-50.
4. Besarab A, Amin N, Ahsan M, et al. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol. 2000;11:530-538. (Pubitemid 30115083)
5. Kaysen GA, Müller HG, Ding J, Chertow GM. Challenging the validity of the EPO index. Am J Kidney Dis. 2006;47:166.e1- 166.e13.
6. Chazot C, Wabel P, Chamney P, Moissl U, Wieskotten S, Wizemann V. Importance of normohydration for the long-term survival of hemodialysis patients. Nephrol Dial Transplant. 2012; 27:2404-2410.
7. Wizemann V, Rode C, Wabel P. Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients. Contrib Nephrol. 2008;161:115-118.
8. Machek P, Jirka T, Moissl U, Chamney P, Wabel P. Guided optimization of fluid status in hemodialysis patients. Nephrol Dial Transplant. 2010;25:538-544.
9. Earthman C, Traughber D, Dobratz J, Howell W. Bioimpedance spectroscopy for clinical assessment of fluid distribution and body cell mass. Nutr Clin Pract. 2007;22:389-405.
10. Wabel P, Chamney P, Moissl U, Jirka T. Importance of whole body bioimpedance spectroscopy for the managment of the fluid balance. Blood Purif. 2009;27:75-80.
11. Kotanko P, Nathan W, Levin W, Zhun F. Current state of bioimpedance technologies in dialysis. Nephrol Dial Transplant. 2008;23:808-812. (Pubitemid 351767595)
12. Basile C, Vernaglione L, Di Iorio B, et al. Development and validation of bioimpedance analysis prediction equations for dry weight in hemodialysis patients. Clin J Am Soc Nephrol. 2007;2: 675-680.
13. Kotanko P, Thijssen S, Levin NW. Association between erythropoietin responsiveness and body composition in dialysis patients. Blood Purif. 2008;26:82-89.
14. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW. Body mass index and mortality in 'healthier' as compared with 'sicker' hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001;16:2386-2394. (Pubitemid 33133852)
15. Ricks J, Molnar MZ, Kovesdy CP, et al. Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. Am J Kidney Dis. 2011;7: 122-131.
16. Molnar MZ, Streja E, Kovesdy CP, et al. Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant. 2011;11: 725-736.
17. Streja E, Kovesdy CP, Molnar MZ, et al. Role of nutritional status and inflammation in higher survival of african american and Hispanic hemodialysis patients. Am J Kidney Dis. 2011;57: 883-893.
18. Campbell KL, MacLaughlin HL. Unintentional weight loss is an independent predictor of mortality in a hemodialysis population. J Ren Nutr. 2010;20:414-418.
19. Jahromi SR, Hosseini S, Razeghi E, Meysamie A, Sadrzadeh H. Malnutrition predicting factors in hemodialysis patients. Saudi J Kidney Dis Transpl. 2010;21:846-851.
20. Kovesdy CP, Shinaberger CS, Kalantar-Zadeh K. Epidemiology of dietary nutrient intake in ESRD. Semin Dial. 2010;23:353-358.
21. Sarkar SR, Kuhlmann MK, Kotanko P, et al. Metabolic consequences of body size and body composition in hemodialysis patients. Kidney Int. 2006;70:1832-1839. (Pubitemid 44684816)
22. Verdalles U, Abad S, Vega A, et al. Factors related to the absence of anemia in hemodialysis patients. Blood Purif. 2011;32:69-74.
23. Chamney PW, Wabel P, Moissl UM, et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007;85:80-89. (Pubitemid 46067619)
24. Afsar S, Saglam M, Yuceturk C, Azca E. The relationship between red cell distribution width with erythropoietin resistance in iron replete hemodialysis patients. Eur J Inter Med. 2013;24:25-29.
25. Axelsson J, Qureshi AR, Heimbürger O, et al. Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. Am J Kid Dis. 2005;46:628-634. (Pubitemid 41383940)